Page last updated: 2024-10-21

5-methoxytryptamine and Liver Neoplasms

5-methoxytryptamine has been researched along with Liver Neoplasms in 1 studies

5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zuboy, J1

Other Studies

1 other study available for 5-methoxytryptamine and Liver Neoplasms

ArticleYear
Maxamine enhances IL-2 in phase 3 malignant cancer.
    Current treatment options in oncology, 2000, Volume: 1, Issue:3

    Topics: 5-Methoxytryptamine; Clinical Trials, Phase III as Topic; Drug Synergism; Drug Therapy, Combination;

2000